Delivery Order SPE2DR25D2104-SPE2DR26F3PHD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a competitively procured delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 100 mg with a ceiling value of $8,140.65. The delivery order is firm fixed price and must be completed by November 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Topiramate 100 mg. This contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,177.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Topiramate 25 mg. This contract, which was competitively awarded without set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of June 6, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract derived from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,034.90 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with a completion date of April 28, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a routine pharmaceutical supply order to support federal medical procurement needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Topiramate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,171.44. This firm fixed-price delivery order, which is not set-aside for any socioeconomic program, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded a $7,809.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of November 17, 2025. This non-competitive, non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.72 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PHDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,186.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 50 mg, with an ultimate completion date of November 19, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems. Topiramate is a generic anticonvulsant and migraine prevention medication commonly used in military medical supply chains. This delivery order exemplifies the company's role as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare systems, leveraging its expansive IDC to fulfill routine medication resupply needs across the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/18/25 |